2023 MIPS Measures Relevant to Dermatology

Quality - 30% of total score:  Report 6 measures, including one Outcome or other High Priority measure for 12 months on at least 70% of eligible encounters to receive a score against 2022 National Benchmarks. Suggestions for your specialty include, but are not limited to, the following:   

ID:
130
NQF:
eMeasure ID:
CMS68v12
High Priority:
Yes

2023 MIPS Measure #130: Documentation of Current Medications in the Medical Record

Percentage of visits for patients aged 18 years and older for which the eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.

Measure Type
  • Process
Specifications
Specialty
  • Allergy/Immunology
  • Audiology
  • Cardiology
  • Certified Nurse Midwife
  • Clinical Social Work
  • Dermatology
  • Endocrinology
  • Family Medicine
  • Gastroenterology
  • General Surgery
  • Geriatrics
  • Hospitalists
  • Infectious Disease
  • Internal Medicine
  • Mental/Behavioral Health
  • Nephrology
  • Neurology
  • Neurosurgery
  • Nutrition/Dietician
  • Obstetrics/Gynecology
  • Oncology/Hematology
  • Ophthalmology
  • Orthopedic Surgery
  • Otolaryngology
  • Physical Medicine
  • Physical Therapy/Occupational Therapy
  • Plastic Surgery
  • Preventive Medicine
  • Pulmonology
  • Rheumatology
  • Speech/Language Pathology
  • Thoracic Surgery
  • Urgent Care
  • Urology
  • Vascular Surgery
ID:
137
NQF:
eMeasure ID:
High Priority:
Yes

2023 MIPS Measure #137: Melanoma: Continuity of Care – Recall System

Percentage of patients, regardless of age, with a current diagnosis of melanoma or a history of melanoma whose information was entered, at least once within a 12 month period, into a recall system that includes:

  • A target date for the next complete physical skin exam, AND
  • A process to follow up with patients who either did not make an appointment within the specified timeframe or who missed a scheduled appointment
Measure Type
  • Structure
Specifications
Specialty
  • Dermatology
ID:
138
NQF:
eMeasure ID:
High Priority:
Yes

2023 MIPS Measure #138: Melanoma: Coordination of Care

Percentage of patient visits, regardless of age, with a new occurrence of melanoma that have a treatment plan documented in the chart that was communicated to the physician(s) providing continuing care within one month of diagnosis.

Measure Type
  • Process
Specifications
Specialty
  • Dermatology
ID:
176
NQF:
eMeasure ID:
High Priority:
No

2023 MIPS Measure #176: Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy

If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month period.

Measure Type
  • Process
Specifications
Specialty
  • Dermatology
  • Family Medicine
  • Infectious Disease
  • Internal Medicine
  • Rheumatology
ID:
226
NQF:
0028
eMeasure ID:
CMS138v11
High Priority:
No

2023 MIPS Measure #226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within the measurement period AND who received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period if identified as a tobacco user.

Measure Type
  • Process
Specifications
Specialty
  • Allergy/Immunology
  • Audiology
  • Cardiology
  • Certified Nurse Midwife
  • Clinical Social Work
  • Dermatology
  • Endocrinology
  • Family Medicine
  • Gastroenterology
  • General Surgery
  • Geriatrics
  • Infectious Disease
  • Internal Medicine
  • Mental/Behavioral Health
  • Nephrology
  • Neurology
  • Neurosurgery
  • Nutrition/Dietician
  • Obstetrics/Gynecology
  • Oncology/Hematology
  • Ophthalmology
  • Orthopedic Surgery
  • Otolaryngology
  • Physical Medicine
  • Physical Therapy/Occupational Therapy
  • Plastic Surgery
  • Podiatry
  • Preventive Medicine
  • Pulmonology
  • Radiation Oncology
  • Rheumatology
  • Speech/Language Pathology
  • Thoracic Surgery
  • Urgent Care
  • Urology
  • Vascular Surgery
ID:
317
NQF:
eMeasure ID:
CMS22v11
High Priority:
No

2023 MIPS Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

Percentage of patient visits for patients aged 18 years and older seen during the measurement period who were screened for high blood pressure AND a recommended follow-up plan is documented, as indicated, if blood pressure is elevated or hypertensive.

Measure Type
  • Process
Specifications
Specialty
  • Allergy/Immunology
  • Cardiology
  • Dermatology
  • Emergency Medicine
  • Family Medicine
  • Gastroenterology
  • General Surgery
  • Internal Medicine
  • Mental/Behavioral Health
  • Nephrology
  • Neurology
  • Obstetrics/Gynecology
  • Oncology/Hematology
  • Orthopedic Surgery
  • Otolaryngology
  • Physical Medicine
  • Plastic Surgery
  • Preventive Medicine
  • Rheumatology
  • Skilled Nursing Facility
  • Urgent Care
  • Urology
  • Vascular Surgery
ID:
374
NQF:
eMeasure ID:
CMS50v11
High Priority:
Yes

2023 MIPS Measure #374: Closing the Referral Loop: Receipt of Specialist Report

Percentage of patients with referrals, regardless of age, for which the referring clinician receives a report from the clinician to whom the patient was referred.

Measure Type
  • Process
Specifications
Specialty
  • Allergy/Immunology
  • Cardiology
  • Dermatology
  • Endocrinology
  • Family Medicine
  • Gastroenterology
  • General Surgery
  • Internal Medicine
  • Interventional Radiology
  • Neurology
  • Obstetrics/Gynecology
  • Oncology/Hematology
  • Ophthalmology
  • Orthopedic Surgery
  • Otolaryngology
  • Physical Medicine
  • Preventive Medicine
  • Pulmonology
  • Rheumatology
  • Thoracic Surgery
  • Urology
  • Vascular Surgery
ID:
402
NQF:
eMeasure ID:
High Priority:
No

2023 MIPS Measure #402: Tobacco Use and Help with Quitting Among Adolescents

The percentage of adolescents 12 to 20 years of age with a primary care visit during the measurement year for whom tobacco use status was documented and received help with quitting if identified as a tobacco user

Measure Type
  • Process
Specifications
Specialty
  • Allergy/Immunology
  • Cardiology
  • Clinical Social Work
  • Dermatology
  • Family Medicine
  • Gastroenterology
  • General Surgery
  • Internal Medicine
  • Mental/Behavioral Health
  • Neurology
  • Obstetrics/Gynecology
  • Oncology/Hematology
  • Orthopedic Surgery
  • Otolaryngology
  • Pediatrics
  • Physical Medicine
  • Preventive Medicine
  • Pulmonology
  • Rheumatology
  • Thoracic Surgery
  • Urgent Care
  • Vascular Surgery
ID:
410
NQF:
eMeasure ID:
High Priority:
Yes

2023 MIPS Measure #410: Psoriasis: Clinical Response to Systemic Medications

Percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician-or patient- reported disease activity levels. It is implied that establishment and maintenance of an established minimum level of disease control as measured by physician-and/or patient-reported outcomes will increase patient satisfaction with and adherence to treatment.

Measure Type
  • Outcome
Specifications
Specialty
  • Dermatology
ID:
440
NQF:
eMeasure ID:
High Priority:
Yes

2023 MIPS Measure #440: Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician

Percentage of biopsies with a diagnosis of cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within 7 days from the time when the tissue specimen was received by the pathologist.

Measure Type
  • Process
Specifications
Specialty
  • Dermatology
  • Pathology
ID:
485
NQF:
eMeasure ID:
High Priority:
Yes

2023 MIPS Measure #485: Psoriasis – Improvement in Patient-Reported Itch Severity

The percentage of patients, aged 18 years and older, with a diagnosis of psoriasis where at an initial (index) visit have a patient reported itch severity assessment performed, score greater than or equal to 4, and who achieve a score reduction of 2 or more points at a follow up visit.

Measure Type
  • Outcome
Specifications
Specialty
  • Dermatology
ID:
486
NQF:
eMeasure ID:
High Priority:
Yes

2023 MIPS Measure #486: Dermatitis – Improvement in Patient-Reported Itch Severity

The percentage of patients, aged 18 years and older, with a diagnosis of dermatitis where at an initial (index) visit have a patient reported itch severity assessment performed, score greater than or equal to 4, and who achieve a score reduction of 2 or more points at a follow up visit.

Measure Type
  • Outcome
Specifications
Specialty
  • Dermatology
ID:
487
NQF:
eMeasure ID:
High Priority:
Yes

2023 MIPS Measure #487: Screening for Social Drivers of Health

Percent of patients 18 years and older screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety.

Measure Type
  • Process
Specifications
Specialty
  • Allergy/Immunology
  • Audiology
  • Cardiology
  • Certified Nurse Midwife
  • Chiropractic Medicine
  • Clinical Social Work
  • Dermatology
  • Emergency Medicine
  • Endocrinology
  • Family Medicine
  • Gastroenterology
  • General Surgery
  • Geriatrics
  • Infectious Disease
  • Internal Medicine
  • Interventional Radiology
  • Mental/Behavioral Health
  • Nephrology
  • Neurology
  • Neurosurgery
  • Nutrition/Dietician
  • Obstetrics/Gynecology
  • Oncology/Hematology
  • Ophthalmology
  • Orthopedic Surgery
  • Otolaryngology
  • Pediatrics
  • Physical Medicine
  • Physical Therapy/Occupational Therapy
  • Plastic Surgery
  • Podiatry
  • Preventive Medicine
  • Pulmonology
  • Rheumatology
  • Skilled Nursing Facility
  • Thoracic Surgery
  • Urgent Care
  • Urology
  • Vascular Surgery

 

  1. PI: Promoting Interoperability - 25% of total score: For a minimum of 90 days, report all required measures. EHR technology certified to the 2015 Edition certification must be in place by October 3, 2022. There are exclusions available for most of the required measures. Please check your QPP Participation Status to see if you are automatically exempt from PI. If you are exempt, the 25% will be re-weighted to the Quality performance category making it 55% of your score.
  2. IA: Improvement Activities - 15% of total score: Attest that you completed up to 2 high-weighted activities or 4 medium-weighted activities for a minimum of 90 days. Groups with 15 or fewer participants or if you are in a rural or health professional shortage area,  attest that you completed 1 high-weighted or 2 medium-weighted activities for a minimum of 90 days. A group can attest to an activity when at least 50% of the clinicians in the group perform the same activity during any continuous 90-day period (or as specified in the activity description) in the same performance year. The following is a sampling of some of the published IA's that might be applicable to your specialty:

Register with MDinteractive